{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:38:22Z","timestamp":1787924302139,"version":"build-2784847793"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jdermsci.2015.07.012","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T15:01:19Z","timestamp":1437922879000},"page":"33-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients"],"prefix":"10.1016","volume":"80","author":[{"given":"Kaori","family":"Sakaizawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyasu","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohito","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Takenouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuhei","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Uhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2015.07.012_bib0110","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0115","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0120","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0125","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1755-148X.2011.00837.x","article-title":"BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site","author":"Bauer","year":"2011","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2011.06.056","article-title":"Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort","volume":"48","author":"Si","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/jid.2012.338","article-title":"BRAF mutations and KIT aberrations and their clinicopathological correlation in 202 Korean melanomas","volume":"133","author":"Jin","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2012.03.005","article-title":"Assessment of BRAF and KIT mutations in Japanese melanoma patients","volume":"66","author":"Ashida","year":"2012","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0150","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1126\/science.1127515","article-title":"MC1R germline variants confer risk for BRAF-mutant melanoma","volume":"313","author":"Landi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0155","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1158\/1078-0432.CCR-12-0052","article-title":"Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma","volume":"18","author":"Menzies","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0160","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1523-1747.1998.00376.x","article-title":"N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin","volume":"111","author":"Jiveskog","year":"1998","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0165","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10147-013-0573-2","article-title":"NRAS mutations in primary and metastatic melanomas of Japanese patients","volume":"19","author":"Uhara","year":"2014","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0175","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1002\/cncr.28306","article-title":"Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma","volume":"119","author":"Bucheit","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0180","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2133.2010.10185.x","article-title":"Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis","volume":"164","author":"Lee","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0185","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10147-007-0751-1","article-title":"Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update","volume":"13","author":"Ishihara","year":"2008","journal-title":"Int. J. Clin. Oncol."},{"issue":"March (3)","key":"10.1016\/j.jdermsci.2015.07.012_bib0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(13)70024-X","article-title":"MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study","volume":"14","author":"Ascierto","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0195","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.bcp.2010.04.032","article-title":"Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics","volume":"80","author":"Woodman","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0200","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1245\/s10434-013-3373-z","article-title":"The GIST of targeted therapy for malignant melanoma","volume":"21","author":"Bello","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1158\/1078-0432.CCR-10-2276","article-title":"Clinical correlates of NRAS and BRAF mutations in primary human melanoma","volume":"17","author":"Ellerhorst","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jdermsci.2015.07.012_bib0210","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/bjc.2012.12","article-title":"Mutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level","volume":"106","author":"Sakaizawa","year":"2012","journal-title":"Br. J. Cancer"}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181115300311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181115300311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T17:20:03Z","timestamp":1537464003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181115300311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0923181115300311"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2015.07.012","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2015.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}